The global computed tomography market was valued at $5,625.0 million in 2020, and is projected to reach $9,919.0 million by 2030, registering a CAGR of 5.7% from 2021 to 2030. Computed tomography (CT) previously known as computed axial tomography or CT scan, is a noninvasive medical imaging method used in radiology to provide comprehensive pictures of the body for diagnostic reasons. A computed tomography (CT) scan combines a series of X-ray images collected from various angles throughout human body and utilizes computer processing to generate cross-sectional images (slices) of bones and soft tissues. These slices are referred to as tomographic pictures, as they provide more comprehensive information than traditional X-rays.
Traditional X-ray machines employ a fixed tube to direct X-rays to a particular location. CT scans use a doughnut-shaped tube that spins the X-ray around an individual 360 degrees. The information gathered gives a comprehensive 3D picture of the interior of the body. It is used to examine almost all areas of the body, diagnose disease or injury, and plan medical, surgical, or radiation therapy. The cross-sectional images produced by a CT scan can be reformatted in several planes and even produce three-dimensional (3D) images that can be seen on a computer display, printed on film, or transmitted to electronic devices.
CT scan is frequently used as the most effective approach for diagnosing many different types of cancer since the pictures allow doctors to confirm the presence of a tumor as well as its size and location. CT scan is painless and noninvasive process. It can disclose internal injuries and bleeding early enough in an emergency situation to help save lives. It can be used in patients with metallic implants or pacemakers where magnetic resonance imaging (MRI) is contraindicated.
The growth of the global computed tomography market is majorly driven by the rise in geriatric population and increase in chronic diseases among the overall population. Thus, surge in incidences of various types of diseases such as cardiovascular, oncology, orthopedic and neurological disorders lead to rise in the usage of CT system that enhances the growth of the market. Computed tomography is widely used to aid in the diagnosis of various tumors, circulatory (blood) system diseases, conditions such as coronary artery disease (atherosclerosis), blood vessel aneurysms, blood clots, orthopedic conditions &fractures, spinal conditions, kidney, bladder stones, abscesses, inflammatory diseases such as ulcerative colitis, sinusitis; and head, skeletal system, &internal organ injuries. According to the Harvard Medical School in 2021, more than 80 million CT scans are performed in the U.S. each year, compared with just 3 million in 1980.
Increase in prevalence of cancer is one of the major reasons for the boost of the computed tomography scans. It shows a tumor's shape, size, &location and even displays the blood vessels that feed the tumor all without having to cut into the patient thus being minimally invasive technique known as CT-guided biopsy. CT scans can be used to guide into tumors during various cancer therapies, such as radiofrequency ablation (RFA), which utilizes heat to kill malignancies. It aids to assess how a tumor responds to treatment or if the cancer has returned after treatment by comparing CT images taken over time.
According to the International Agency for Research on Cancer (IARC), the updated Globocan data of 2020, there were an estimated around 19.3 million cases of cancer. According to World Health Organization (WHO), cancer is a leading cause of death worldwide and approximately 70% of deaths from cancer occur in low& middle income countries. By 2040, the number of new cases of cancer per year is expected to rise to 29.5 million and the number of cancer-related deaths is expected to increase to 16.4 million. Thus, rise in prevalence of cancer is anticipated to drive the growth of computed tomography market.
Cardiovascular diseases (CVDs) are the leading cause of death globally, and it takes an estimated 17.9 million lives each year. According to report of the British Heart Foundation in 2021, 7.6 million people live with heart &circulatory diseases and it causes about 25% death in the UK. Cardiovascular diseases are a group of disorders of the heart &blood vessels and it include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. A heart computerized tomography (CT) scan, also called a calcium-score screening heart scan, is used to find calcium deposits in people with heart disease. It is an efficient method of detecting atherosclerosis before symptoms appear. The more coronary calcium, the more coronary atherosclerosis persists, which increases the chances of developing cardiovascular issues in the future. Thus, surge in cardiovascular diseases due to stress, unhealthy lifestyle, and oily food consumptions are expected to drive the computed tomography market.
In addition, technological advancements for development of new products, growth in patient emphasis for early detection of diseases, rise in global prevalence of targeted diseases coupled with an aging population, increased preference for minimally invasive diagnostic procedures and surge in benefits of CT scans over other imaging modalities are factors that are anticipated to drive the growth of the computed tomography market.
On the contrary, the high cost of the implementation of CT scan instruments &their maintenance, compliance with regulatory requirements in developing countries, lack of reimbursement in some countries, and adverse side effects from its radiation can lead to cancer as well, which may hinder the growth of the market.
Emerging markets &significant R&D to develop efficient computed tomography instruments, innovation of various systems, and unmet demand in the under developed &developing countries are projected to provide substantial growth opportunities for key players in computed tomography market.
The computed tomography market is segmented onto the basis of type, application, end user and region. On the basis of type, the market is categorized into low slice, medium slice, and high slice. By application, the market is fragmented into oncology, neurology, cardiovascular, musculoskeletal, and others. By end user, the market is categorized intohospitals & clinic, diagnostic centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global computed tomography market are Cannon Medical Systems Corporation, Fujifilm Holdings Corporation, GE Healthcare, Koning Corporation, Koninklijke Philips NV, Neurologica Corporation, Neusoft Medical Systems CO. Ltd., Shimadzu Corporation, Siemens Healthineers, and Stryker Corporation.
Traditional X-ray machines employ a fixed tube to direct X-rays to a particular location. CT scans use a doughnut-shaped tube that spins the X-ray around an individual 360 degrees. The information gathered gives a comprehensive 3D picture of the interior of the body. It is used to examine almost all areas of the body, diagnose disease or injury, and plan medical, surgical, or radiation therapy. The cross-sectional images produced by a CT scan can be reformatted in several planes and even produce three-dimensional (3D) images that can be seen on a computer display, printed on film, or transmitted to electronic devices.
CT scan is frequently used as the most effective approach for diagnosing many different types of cancer since the pictures allow doctors to confirm the presence of a tumor as well as its size and location. CT scan is painless and noninvasive process. It can disclose internal injuries and bleeding early enough in an emergency situation to help save lives. It can be used in patients with metallic implants or pacemakers where magnetic resonance imaging (MRI) is contraindicated.
The growth of the global computed tomography market is majorly driven by the rise in geriatric population and increase in chronic diseases among the overall population. Thus, surge in incidences of various types of diseases such as cardiovascular, oncology, orthopedic and neurological disorders lead to rise in the usage of CT system that enhances the growth of the market. Computed tomography is widely used to aid in the diagnosis of various tumors, circulatory (blood) system diseases, conditions such as coronary artery disease (atherosclerosis), blood vessel aneurysms, blood clots, orthopedic conditions &fractures, spinal conditions, kidney, bladder stones, abscesses, inflammatory diseases such as ulcerative colitis, sinusitis; and head, skeletal system, &internal organ injuries. According to the Harvard Medical School in 2021, more than 80 million CT scans are performed in the U.S. each year, compared with just 3 million in 1980.
Increase in prevalence of cancer is one of the major reasons for the boost of the computed tomography scans. It shows a tumor's shape, size, &location and even displays the blood vessels that feed the tumor all without having to cut into the patient thus being minimally invasive technique known as CT-guided biopsy. CT scans can be used to guide into tumors during various cancer therapies, such as radiofrequency ablation (RFA), which utilizes heat to kill malignancies. It aids to assess how a tumor responds to treatment or if the cancer has returned after treatment by comparing CT images taken over time.
According to the International Agency for Research on Cancer (IARC), the updated Globocan data of 2020, there were an estimated around 19.3 million cases of cancer. According to World Health Organization (WHO), cancer is a leading cause of death worldwide and approximately 70% of deaths from cancer occur in low& middle income countries. By 2040, the number of new cases of cancer per year is expected to rise to 29.5 million and the number of cancer-related deaths is expected to increase to 16.4 million. Thus, rise in prevalence of cancer is anticipated to drive the growth of computed tomography market.
Cardiovascular diseases (CVDs) are the leading cause of death globally, and it takes an estimated 17.9 million lives each year. According to report of the British Heart Foundation in 2021, 7.6 million people live with heart &circulatory diseases and it causes about 25% death in the UK. Cardiovascular diseases are a group of disorders of the heart &blood vessels and it include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. A heart computerized tomography (CT) scan, also called a calcium-score screening heart scan, is used to find calcium deposits in people with heart disease. It is an efficient method of detecting atherosclerosis before symptoms appear. The more coronary calcium, the more coronary atherosclerosis persists, which increases the chances of developing cardiovascular issues in the future. Thus, surge in cardiovascular diseases due to stress, unhealthy lifestyle, and oily food consumptions are expected to drive the computed tomography market.
In addition, technological advancements for development of new products, growth in patient emphasis for early detection of diseases, rise in global prevalence of targeted diseases coupled with an aging population, increased preference for minimally invasive diagnostic procedures and surge in benefits of CT scans over other imaging modalities are factors that are anticipated to drive the growth of the computed tomography market.
On the contrary, the high cost of the implementation of CT scan instruments &their maintenance, compliance with regulatory requirements in developing countries, lack of reimbursement in some countries, and adverse side effects from its radiation can lead to cancer as well, which may hinder the growth of the market.
Emerging markets &significant R&D to develop efficient computed tomography instruments, innovation of various systems, and unmet demand in the under developed &developing countries are projected to provide substantial growth opportunities for key players in computed tomography market.
The computed tomography market is segmented onto the basis of type, application, end user and region. On the basis of type, the market is categorized into low slice, medium slice, and high slice. By application, the market is fragmented into oncology, neurology, cardiovascular, musculoskeletal, and others. By end user, the market is categorized intohospitals & clinic, diagnostic centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global computed tomography market are Cannon Medical Systems Corporation, Fujifilm Holdings Corporation, GE Healthcare, Koning Corporation, Koninklijke Philips NV, Neurologica Corporation, Neusoft Medical Systems CO. Ltd., Shimadzu Corporation, Siemens Healthineers, and Stryker Corporation.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global advanced drug delivery market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region- & country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Product Type
- Low Slice (< 64 Slices)
- Medium Slice (64 Slices)
- High Slice (>64 Slice)
By End User
- Hospitals
- Diagnostic Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Alnylam Pharmaceuticals Inc.
- Altaris Capital Partners Llc. (Kindeva Drug Delivery)
- Bausch Health Companies Inc., (Bausch & Lomb)
- Biogen Limited
- Endo International Plc.
- Johnson & Johnson (Johnson & Johnson Vision)
- Micropoint Technologies
- Novo Nordisk A/S
- Ocular Therapeutix Inc.
- Takeda Pharmaceutical Company Limited
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: COMPUTED TOMOGRAPHY MARKET, BY TYPE
CHAPTER 5: COMPUTED TOMOGRAPHY MARKET, BY APPLICATION
CHAPTER 6: COMPUTED TOMOGRAPHY MARKET, BY END USER
CHAPTER 7: COMPUTED TOMOGRAPHY MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES: COMPUTED TOMOGRAPHY (CT) MARKET
List of Tables
List of Figures
Companies Mentioned
- Cannon Medical Systems Corporation
- Fujifilm Holdings Corporation
- GE Healthcare
- Koning Corporation
- Koninklijke Philips NV
- Neurologica Corporation
- Neusoft Medical Systems CO.Ltd.
- Shimadzu Corporation
- Siemens Healthineers
- Stryker Corporation
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 253 |
| Published | December 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 5625 million |
| Forecasted Market Value ( USD | $ 9919 million |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
